Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anaphylactic shock | x | x | x | x | x | x | x | |||
| Angioedema | x | x | x | x | x | |||||
| Cold urticaria | x | x | x | x | ||||||
| Conjunctivitis | x | x | x | |||||||
| Conjunctivitis allergic | x | x | x | x | ||||||
| Hypersensitivity | x | x | x | x | x | x | x | |||
| Rhinitis allergic | x | x | x | |||||||
| Seasonal allergy | x | x | x | x | ||||||
| Urticaria | x | x | x | x | x | x | x | |||
| Urticaria physical | x | x | x | x | ||||||
| Vasomotor rhinitis | x | x | x | x | ||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |